企業プロフィール
Veeva 株価・ニュース・カタリスト
- ティッカー:
- VEEV
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
238.34 USD (-2.22%)
終値
最終更新: 2026年8月17日
29.9B USD
時価総額
株価変動の要因
As of Aug 17, 2026, VEEV closed down 2.22% at $238.34. No new same-company headline was identified in the current news window.
企業概要
事業概要
Veeva Systems is a cloud software company built specifically for the life sciences industry. Its core products support commercial, clinical, regulatory, and data workflows for pharma and biotech customers, making it a key infrastructure name rather than a therapeutic developer.
所在地とセクター分類
Headquartered in the United States and listed on NYSE, Veeva has a global footprint across life sciences companies. It sits in enterprise software and life sciences technology, not biotechnology proper.
ビジネスモデルの特徴
The business relies on recurring software subscriptions, customer retention, and cross-sell across commercial and development workflows. Investors tend to watch subscription growth, operating margin, product expansion, and the strength of the broader life sciences spending environment.
バイオ業界での位置付け
Veeva is one of the most important software platforms in the biotech ecosystem. It is not a drug stock, but it matters because it helps power commercial and clinical operations across the sector.
今後のカタリスト
- Veeva’s catalysts are Vault CRM adoption, clinical-data-cloud traction, and continued penetration of regulated-life-science software. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。